This article was originally published by Targeted Oncology. C. Ola Landgren, MD, PhD, chief of Myeloma Service and hematologic oncologist at...
News
Upcoming patient seminar: Hamilton
Hamilton Myeloma Semimar, Saturday 5 September Come along to our Hamilton Myeloma Patient Seminar, hosted by MyelomaNew Zealand and Leukaemia &...
GSK nabs FDA approval for first-in-class multiple myeloma drug
Blenrep, an antibody-drug conjugate, is the first drug approved for multiple myeloma that targets the antigen BCMA. Several other companies are also...
Wave of New Therapies Improve Outcomes for Patients with Multiple Myeloma
For many patients with multiple myeloma, a new generation of drugs and drug combinations is producing better outcomes and fewer side effects. In...
“Good-Risk” Group of Patients With Myeloma Saw Better Outcomes
This article was originally published by Cancer Therapy Advisor Researchers have used deep whole-genome sequencing (WGS) to identify genomic markers...
Severe Renal Impairment Worsens Outcomes in Multiple Myeloma
This was originally published by AJMC Severe renal impairment (RI) is associated with decreased rates of survival among patients with multiple...
Inpatient Mortality With Renal Impairment in Patients With Multiple Myeloma
This article was originally published by Cancer Therapy Advisor Receipt of dialysis may be a risk factor for inpatient mortality in patients with...
EU Approval Urged for GSX’s Belantamab Mafodotin for Heavily Treated Myeloma
This post was originally published by Myeloma Research News GlaxoSmithKline’s investigational therapy belantamab mafodotin has been...
FDA Office Favors Antibody-drug Conjugate for Advanced Multiple Myeloma
An office of the U.S. Food and Drug Administration (FDA has recommended that belantamab mafodotin, GlaxoSmithKline’s investigational...
Upcoming Patient Seminar: Whangarei Myeloma Seminar
Come along to our Whangarei Myeloma Patient Seminar, hosted by Myeloma New Zealand and Leukaemia & Blood cancer New Zealand. During the evening,...
Case Report Describes Late-onset MG in Man Treated for Multiple Myeloma
This post was originally published by Myasthenia Gravis News A 60-year-old man being treated for multiple myeloma was found to...
HealthTree® Launches HealthTree University for Multiple Myeloma Patients
This was originally posted by Cision PR Newswire SALT LAKE CITY, July 9, 2020 /PRNewswire/ -- HealthTree®, the first online portal...